Time-course of Mitochondrial Biogenic Gene and Protein Expression in Exercised Human Skeletal Muscle
Impact of Exercise Intensity on the Time-course of Mitochondrial Biogenic Gene and Protein Expression in Human Skeletal Muscle.
1 other identifier
interventional
10
1 country
1
Brief Summary
This study examines the impact of exercise intensity on the 12-hour time-course of mitochondrial biogenic gene and protein expression in human skeletal muscle. Briefly, participants will perform two experimental sessions involving an acute bout of work-matched low- or high-intensity interval cycling exercise in a randomized crossover fashion, two weeks apart. Skeletal muscle biopsies will be obtained from the vastus lateralis (3 from each leg) before and 1, 3, 6, 9, and 12 hours post-exercise. Changes in the expression of various transcription factors and mitochondrial proteins will be examined at the mRNA and protein level to determine the time-course of changes in these factors differs between exercise protocols of different intensities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedFirst Posted
Study publicly available on registry
June 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedMarch 4, 2020
March 1, 2020
11 months
May 29, 2019
March 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in peroxisome proliferator activated receptor (PPAR) gamma co-activator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA) expression
PGC-1α gene expression (indirect indicator of PGC-1α activity). Transcriptional co-activator involved in the control of mitochondrial biogenesis.
before exercise to 1, 3, 6, 9, and 12 hours post-exercise
Secondary Outcomes (21)
Change in PGC-1α protein content
before exercise to 1, 3, 6, 9, and 12 hours post-exercise
Change in nuclear factor-erythroid 2 like 2 (Nrf2) mRNA expression
before exercise to 1, 3, 6, 9, and 12 hours post-exercise
Change in Nrf2 protein content
before exercise to 1, 3, 6, 9, and 12 hours post-exercise
Change in PPAR-beta mRNA expression
before exercise to 1, 3, 6, 9, and 12 hours post-exercise
Change in estrogen related receptor (ERR)-gamma mRNA expression
before exercise and 1, 3, 6, 9, and 12 hours post-exercise
- +16 more secondary outcomes
Study Arms (2)
low-intensity exercise - high-intensity exercise
EXPERIMENTALlow-intensity exercise session followed by a high-intensity exercise session separated by a minimum of 14 days
high-intensity exercise - low-intensity exercise
EXPERIMENTALhigh-intensity exercise session followed by a low-intensity exercise session separated by a minimum of 14 days
Interventions
Participants will perform an acute bout of low-intensity cycling (11 x 1 min intervals at \~73% of peak aerobic work rate interspersed with 1 min recovery periods)
Participants will perform an acute bout of high-intensity cycling (8 x 1 min intervals at \~100% of peak aerobic work rate interspersed with 1 min recovery periods)
Eligibility Criteria
You may qualify if:
- recreationally active (no more than three hours of structured weekly physical activity)
- not currently involved in a systematic training program for improving cardiorespiratory fitness, muscular strength, and/or sport-specific skills
- body mass index \< 30 kg/m2
You may not qualify if:
- presence of cardiometabolic disease
- taking regular prescription medication for the treatment of cardiometabolic disease
- current cigarette smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Kinesiology and Health Studies
Kingston, Ontario, K7L3N6, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Brendon J. Gurd, PhD
School of Kinesiology and Health Studies
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 29, 2019
First Posted
June 5, 2019
Study Start
June 1, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
March 4, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share